NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Grants > Search Current & Recent Grants > Dolutegravir for the Treatment of HIV in Patients with Tuberculosis in Kwazulu-Natal South Africa Print

COVID-19: COVID-19 public health information from the US CDC | COVID-19 research information from the US NIH | Español | COVID-19 resources for global health researchers

Dolutegravir for the Treatment of HIV in Patients with Tuberculosis in Kwazulu-Natal South Africa

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Dolutegravir for the Treatment of HIV in Patients with Tuberculosis in Kwazulu-Natal South Africa

Principal Institution

Center for the AIDS Program of Research in South Africa (CAPRISA)

Principal Investigator(s) (PI)

Naidoo, Anushka

Project Contact Information

Email: anushka.naidoo@caprisa.org

Year(s) Awarded

2019-2024

Collaborating Country

South Africa

Collaborators

Johns Hopkins University

Related World Regions / Countries

Related Global Health Research Topics